GHA Working Group China

GHA Working Group China

The Working Group China brings together all GHA members who are interested in working on health related issues in China and/or in the Chinese health sector. The working group is co-chaired by Professor Dr med. Dr h.c. Manfred Dietel (Charité) and Verena Kantel (Bayer AG) and meets physically twice a year.

Under the very well-established label in China and activities of the German-Sino Health Care Group (GSHCG) the GHA – German Health Alliance brings together German organizations and leading Chinese stakeholders in the health care sector, sharing know-how and technologies related to integrated health care.

On the basis of a framework agreement between the German Federal Ministry for Economic Affairs and Energy and the National Development and Reform Commission (NDRC), GSHCG-GHA strives to strengthen the bilateral cooperation in all areas of health care.

The GHA Working Group China is also committed in strengthening health policy at the various political levels. The focus is on promoting the foreign policy dimension of German and EU health policy both in bilateral relations with China and even better coordination with China in multilateral forums. In the GHA Working Group China, GHA-BDI position papers were published, in which the health industry positions itself for the first time on a cross-sectoral basis on issues relating to German and EU political cooperation with China.

In addition to the political dimension, the working group focuses on concrete projects to be realized in China and in Germany. As examples in China, the international university hospital planned in Hangzhou, a Comprehensive Cancer Center, and the establishment of a network for digital diagnostics in various fields should be mentioned here. On the other hand, the German side can learn a lot in the field of IT networking in the hospital system of large cities. Projects are also being planned in this area.

Professor Dr Manfred Dietel from GSHCG – GHA at 2019 Sino-German Bioeconomy and Biomedicine Conference

Model of the Sino-German International Hospital, Zhejiang Medical University, Hangzhou

Professor Dr Manfred Dietel from GSHCG – GHA at 2019 Sino-German Bioeconomy and Biomedicine Conference

Hangzhou Talent Conference hosted by Gongshu District on November 9, 2019 with Presence of GSHCG – GHA

2 Working Group meetings per year
Close interaction with the GHA Expert Groups and other GHA Working Groups
Preparation, support and implementation of delegation visits (incoming & outgoing)
Jour fixe of the Working Group Chairs with the GHA Board of Directors
Working Group Report from the chairs at the annual GHA general assembly
Creation and use of a dedicated email distribution list for Working Group members via GHA website and GHA newsletter function

No results found.

GSHCG – GHA

Under the very well-established label and activities of GSHCG, the GHA – German Health Alliance brings together German organizations and leading Chinese stakeholders in the healthcare sector, sharing know-how and technologies related to integrated healthcare.

On basis of a framework agreement between the German Federal Ministry for Economic Affairs and Energy and the National Development and Reform Commission (NDRC), GSHCG-GHA strives to strengthen the bilateral cooperation in all areas of healthcare including:

Hospital Planning
Hospital Management
Medical Technologies and Hospital Equipment
Pharmaceuticals
Research & Development
Education & Training

The China Working Group of GHA, led by Professor Dr Manfred Dietel, Charité, and Verena Kantel, Bayer AG, is elaborating concrete, tangible projects which are executed by joint working groups. In this context, it is intended to build an appropriate and suitable framework for the relevant actors.

BDI-GHA Position Paper

Full Version English

Executive Summary English

Executive Summary German

Exclusive Coverage | August 20, 2020

„Sino-EU and Sino-German Cooperation in Health – how to unleash the health care sector’s full potential for health and wealth”

GHA and BDI have formulated 5 key demands and are committed to a self-confident and pro-active shaping of German-Chinese and EU-Chinese relations in the health sector. More than 60 concrete recommendations are to provide the impetus for a new strategic orientation in health and industrial policy in the EU. The health industry is thereby positioning itself both critically and constructively.

Cooperation with China: GHA and BDI demand strengthening of health policy

The health sector is an economic heavyweight and securing its innovation and competitiveness is a cross-industry and societal concern. In Germany, the healthcare industry contributed a full 12% of gross value added in 2018 and was an employer for over 7 million people. Its innovative capacity enables patients to benefit from new prevention, diagnosis and therapy options. As a job engine, it contributes to the creation of jobs. This benefits society as a whole – in the form of innovative therapy options for patients, but also highly qualified jobs. Digitalization enables new types of diagnostics and therapies such as genome sequencing and personalized medicine. Therefore, BDI and GHA are calling for more investment, a clearer strategic alignment and better framework conditions in the fields of health, innovation and digitalization in both internal and external health policy.

China is an important market and partner in health policy issues

The BDI-GHA position paper “Sino-EU and Sino-German Cooperation in Health – How to Unleash the Health Care Sector’s Full Potential for Health and Wealth” calls on the Federal Government and the EU to improve the political framework conditions in Germany and the EU and to cooperate more closely on health issues. Cooperation on health should also be intensified in relations with China. In concrete terms, BDI and GHA are calling for a health policy at national, EU, and multilateral level that is more innovation- and digitalization-friendly. In bilateral relations with China, they would like to see a structural dialogue that identifies and removes trade and investment obstacles in bilateral relations, and which can be expanded through concrete cooperation projects between companies and research institutes. This would ensure fair access to important foreign markets. In addition, the EU and the People’s Republic of China could jointly strengthen the health care of their 1.8 billion inhabitants through close cooperation between science, research, and the health care industry and jointly provide important impulses for global health policy.

Professor Dr med. Dr. h.c. Manfred Dietel
Charité – University Medicine Berlin
Deputy Chair | GHA – German Health Alliance

Verena Kantel
Bayer AG
GHA Speaker China

Patient orientated diagnostics with special focus on molecular analytics | Healthcare Management | Cancer Research | International Cooperations with focus on China | IT-based telediagnostics

Positioning GHA-BDI in German-Sino Relations and in EU-Sino Relations (Policy Paper, Call for Action) | Advocating Position in Trade Associations, vis a vis German and EU Decision Makers, Chinese Embassy | Representing GHA on Panels, Conferences, Workshops

Professor Dr Manfred Dietel, GSHCG – GHA, at the 2019 Sino-German Bioeconomy and Biomedicine Conference

Verena Kantel, Chinese Chamber of Commerce Germany (CHKD), China Day 2019

Premarajani Sabanantham

GHA Office Berlin
T: +49 30 2028 1571
sabanantham@gha.health

Working Group Forum for GHA Members

Registration for WG for GHA Members